Douglas C. Palmer

发表论文 196 篇 · 总被引 18043 次 · h-index 51

代表论文

1169 AZD5863: a specific, potent, affinity-optimized claudin 18.2 and CD3 binding T cell-engager that elicits low cytokine release and is capable of bystander killing (2023 · Regular and Young Investigator Award Abstracts · 被引 3)
Initial TCR Signal Strength Imprints GATA3 and Tbet Expression Driving T-helper Cell Fate Decisions (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)
2223P First-line (1L) AZD0171 + durvalumab (D) + chemotherapy (CT) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): Phase II study results (2025 · Annals of Oncology · 被引 1)
785 mAZD0171 mediated LIF blockade in combination with chemotherapy and PD-L1 inhibition repolarizes macrophages and increases T cell infiltration via CX3CR1-CX3CL1 axis (2023 · Regular and Young Investigator Award Abstracts · 被引 1)
Abstract 6725: AI-derived H&E biomarkers predict differential survival under immunotherapy vs chemotherapy in phase-3 metastatic NSCLC study NEPTUNE. (2026 · Cancer Research)
GEMINI-NSCLC study: Integrated longitudinal multi-omic biomarker profiling study of non-small cell lung cancer (NSCLC) patients. (2025 · Journal of Clinical Oncology)